NSEAnalysts/Institutional Investor Meet/Con. Call Updates4d ago · 17 Jul 2026, 07:06 pm
Analysts/Institutional Investor Meet/Con. Call Updates
Torrent Pharmaceuticals Limited · TORNTPHARM
✦ AI SummaryResults
Torrent Pharmaceuticals Limited has scheduled a teleconference with investors and analysts on July 30, 2026, to discuss the financial performance for the quarter ended June 30, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Torrent Pharmaceuticals Limited has informed the Exchange about Schedule of meet
Attachments (1)
📄pdf
Download →
TORNTPHARM_17072026190620_SE_Intimation_Concall.pdf
View document text
17th July, 2026
The Dy. General Manager (Listing Dept.) The Manager – Listing Dept.,
BSE Limited., National Stock Exchange of India Ltd.,
Corporate Relationship Dept., Exchange Plaza, 5th Floor,
1st Floor, New Trading Ring, Plot No. C/1, G. Block,
P. J. Towers, Dalal Street, Fort, Bandra - Kurla Complex, Bandra (E),
Mumbai - 400 001 Mumbai – 400 051
(BSE Scrip Code: 500420) (NSE Scrip Code: TORNTPHARM)
Dear Sir,
Sub.: Post Quarterly Financial Result Conference call with investors / analyst
We hereby inform that the Company has scheduled a teleconference with Investors / Analyst on
30th July, 2026 at 05:30 P.M. to discuss the financial performance of the Company for the quarter
ended 30th June, 2026.
Conference call – Dial in information:
Universal dial-in +91 22 6280 1439
+91 22 7115 8803
India National Toll Free 1 800 120 1221
International Toll Free
Argentina 0080014243444
Australia 0080014243444
Belgium 0080014243444
Canada 01180014243444
China 4008428405
France 0800914745
Germany 0080014243444
Hong Kong 800964448
Italy 0080014243444
Japan 00531161110
Netherlands 08000229808
Poland 008001124248
Singapore 8001012045
South Korea 00180014243444
Email – investorservices@torrentpharma.com
Sweden 0080014243444
Thailand 00180014243444
UK 08081011573
USA 18667462133
Diamond Pass Registration Link
https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=4636017
&linkSecurityString=277f6647f0
The above is for your information and record.
Thanking you,
Yours sincerely,
For TORRENT PHARMACEUTICALS LIMITED
CHINTAN M. TRIVEDI
COMPANY SECRETARY
Email – investorservices@torrentpharma.com